Contradictory data have been reported on serum leptin concentrations in patients with SSc (75–78), and it has been suggested that these variations may reflect heterogeneity in disease duration, activity, and different phenotypes and endotypes. The gene discussed is LEP; the disease is systemic sclerosis.